|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.15 HKD | +3.42% |
|
+3.17% | -10.19% |
| Apr. 29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
The Board of Directors of CanSino Biologics Inc. has authorized a buyback plan on January 23, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.19% | 1.17B | |
| -1.28% | 89.37B | |
| +2.76% | 40.65B | |
| -12.32% | 32.81B | |
| +52.41% | 25B | |
| -17.39% | 15.29B | |
| -42.45% | 11.61B | |
| -10.48% | 11.49B | |
| +6.14% | 8.98B | |
| -7.72% | 8.23B |
CANSINO BIOLOGICS INC. 
